NCT06661252View on ClinicalTrials.gov

Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions
Chronic Obstructive Pulmonary Disease (COPD)Asthma PatientsAsthma and RhinitisAsthmatic PatientsAsthma, Chronic Obstructive Pulmonary Disease (COPD)Rhinitis AllergicRhinitis, Allergic, Perennial and/or SeasonalNon-allergic RhinitisChronic Sinusitis With or Without Nasal PolypsHealthy Volunteers
Interventions
DEVICE

ABEL microsampler device

The ABEL microsampler device will be used to collect nasal fluid samples for biomarker analysis.

Trial Locations (1)

3168

RECRUITING

Diag-Nose Medical, Notting Hill

All Listed Sponsors
lead

Diag-Nose Medical Pty Ltd

OTHER